POSSIBILITIES OF ANXIETY-DEPRESSIVE DISORDERS TREATMENT IN PATIENTS WITH CHRONIC HEART FAILURE
Aim. To study the efficacy and safety of D-, L-gopantenic acid/Pantogam active in the complex treatment of congestive heart failure and coronary heart disease in patients with symptoms of anxiety-depressive disorder. Patients and methods. 82 patients with NYHA II-III heart failure, anxiety and depre...
Main Authors: | A. P. Baranov, A. V. Strutynskiy, O. Sh. Oynotkinova, A. A. Baranova, V. V. Trishina, Yu. Yu. Golubev, A. N. Kruzhalov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2017-02-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1050 |
Similar Items
-
Prospects of application of the rac-gopantenicum/d, l-gopantenicum acid (pantogam active) in the treatment of post-stroke affective disorders
by: N. G. Neznanov, et al.
Published: (2018-07-01) -
Hospital Anxiety and Depression in the Elderly with Chronic Heart Failure
by: P Farokhnezhad Afshar, et al.
Published: (2019-11-01) -
THE PREVALENCE AND SEVERITY OF DEPRESSION AND ANXIETY IN HEART FAILURE PATIENTS IN BULGARIA
by: Vasil Kolev, et al.
Published: (2023-11-01) -
The Role of Depression and Anxiety in Frail Patients with Heart Failure
by: Elisabeta Ioana Hiriscau, et al.
Published: (2019-06-01) -
Solid Dosage Forms of Nootropic Action Based on Pantogam and Succinic Acid
by: Denis A. Slivkin, et al.
Published: (2020-10-01)